Skip to content
healthcare.dev

CALQUENCE

NDC 0310-3512, acalabrutinib, tablet, film coated, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-3512
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216387
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3512 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACALABRUTINIB100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Tyrosine Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0310-3512-600031035126060 TABLET, FILM COATED in 1 BOTTLE (0310-3512-60)
0310-3512-950031035129560 TABLET, FILM COATED in 1 BLISTER PACK (0310-3512-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b1409184-3267-4d8c-8f17-4e01f69828b1

Use it

Look up 0310-3512 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3512 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-3512. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.